| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Daniel van den Hove | Q57154516 |
| P2093 | author name string | Laurence Lanfumey | |
| Harry W Steinbusch | |||
| Gunter Kenis | |||
| Fabien Boulle | |||
| Marion J F Levy | |||
| P2860 | cites work | Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder | Q21094858 |
| Deoxygedunin, a natural product with potent neurotrophic activity in mice | Q21136320 | ||
| Untreated Depression and Hippocampal Volume Loss | Q22306281 | ||
| Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group | Q23747515 | ||
| Hippocampal atrophy in recurrent major depression | Q24598190 | ||
| Antidepressants recruit new neurons to improve stress response regulation | Q24634257 | ||
| IGF-I in major depression and antidepressant treatment response | Q48086621 | ||
| Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. | Q48110541 | ||
| Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. | Q48125194 | ||
| Retinal dysfunction of contrast processing in major depression also apparent in cortical activity | Q48138526 | ||
| Blood BDNF concentrations reflect brain-tissue BDNF levels across species | Q48138873 | ||
| Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study | Q48158483 | ||
| The antidepressant effects of ventromedial prefrontal cortex stimulation is associated with neural activation in the medial part of the subthalamic nucleus | Q48165306 | ||
| Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. | Q48180704 | ||
| The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder | Q48188476 | ||
| Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures | Q48203803 | ||
| Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression | Q48208784 | ||
| Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression | Q48219987 | ||
| Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain | Q48266494 | ||
| Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study | Q48289563 | ||
| Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis | Q48303612 | ||
| Effects of single and repeated electroconvulsive stimulation on hippocampal cell proliferation and spontaneous behaviors in the rat. | Q48309514 | ||
| Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients | Q48317806 | ||
| Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth | Q48320909 | ||
| Relationships between Amygdala Volume and Activity during Emotional Information Processing Tasks in Depressed and Never‐Depressed Individuals | Q48320972 | ||
| Fronto-limbic microstructure and structural connectivity in remission from major depression. | Q48363548 | ||
| Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression | Q48364979 | ||
| Neural response to pleasant stimuli in anhedonia: an fMRI study | Q48382285 | ||
| Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects | Q48388265 | ||
| Dysfunctional glutamatergic and γ-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression | Q48399737 | ||
| Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression | Q48405009 | ||
| No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes | Q48406899 | ||
| Lack of ventral striatal response to positive stimuli in depressed versus normal subjects | Q48407950 | ||
| Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala | Q48424645 | ||
| TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination | Q48429365 | ||
| TrkB partial agonists: potential treatment strategy for major depression | Q48448292 | ||
| Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. | Q47986721 | ||
| The hippocampus in aging and disease: From plasticity to vulnerability | Q48076670 | ||
| Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures | Q34548310 | ||
| The impacts of swimming exercise on hippocampal expression of neurotrophic factors in rats exposed to chronic unpredictable mild stress | Q34575302 | ||
| Insulin-like growth factor-I and neurogenesis in the adult mammalian brain | Q34595761 | ||
| Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. | Q34611012 | ||
| Fluoxetine targets early progenitor cells in the adult brain | Q34611258 | ||
| Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression | Q34618440 | ||
| Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine | Q34658028 | ||
| VEGF regulates antidepressant effects of lamotrigine | Q34660588 | ||
| The stressed hippocampus, synaptic plasticity and lost memories | Q34664986 | ||
| Stress, depression, and neuroplasticity: a convergence of mechanisms | Q34686632 | ||
| Stressful life events, genetic liability, and onset of an episode of major depression in women | Q34722337 | ||
| Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates | Q34734974 | ||
| Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies | Q34781872 | ||
| Right and left amygdalae activation in patients with major depression receiving antidepressant treatment, as revealed by fMRI. | Q34804033 | ||
| The current state of the neurogenic theory of depression and anxiety | Q34943860 | ||
| New insights in the biology of BDNF synthesis and release: implications in CNS function | Q34965414 | ||
| Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression | Q35004325 | ||
| Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression | Q35012957 | ||
| Long-term potentiation and long-term depression: a clinical perspective | Q35054973 | ||
| Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis | Q35085459 | ||
| Neuroimaging Abnormalities in the Amygdala in Mood Disorders | Q35118453 | ||
| Near-infrared spectroscopy for examination of prefrontal activation during cognitive tasks in patients with major depressive disorder: a meta-analysis of observational studies | Q35181685 | ||
| Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment | Q35562268 | ||
| 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease | Q35622640 | ||
| Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study | Q35629122 | ||
| Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder | Q35659957 | ||
| BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity | Q35837743 | ||
| Brain-derived neurotrophic factor and neuropsychiatric disorders | Q35847085 | ||
| Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals. | Q35887030 | ||
| Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression. | Q36031052 | ||
| Antidepressant-like Effects of Electroconvulsive Seizures Require Adult Neurogenesis in a Neuroendocrine Model of Depression. | Q36054353 | ||
| Frontostriatal functional connectivity in major depressive disorder | Q36061734 | ||
| Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy | Q36100400 | ||
| Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications | Q24649095 | ||
| The molecular neurobiology of depression | Q24656261 | ||
| Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents | Q24656267 | ||
| Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior | Q24679793 | ||
| Possible contribution of IGF-1 to depressive disorder | Q27002937 | ||
| Emotion circuits in the brain | Q27860733 | ||
| Nerve growth factor signaling, neuroprotection, and neural repair | Q27919616 | ||
| Neurogenesis in the adult human hippocampus | Q28288339 | ||
| A Synthetic 7,8-Dihydroxyflavone Derivative Promotes Neurogenesis and Exhibits Potent Antidepressant Effect | Q28298196 | ||
| The mesolimbic dopamine reward circuit in depression | Q28304016 | ||
| Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice | Q28473290 | ||
| Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade | Q28478486 | ||
| TrkB agonist antibody pretreatment enhances neuronal survival and long-term sensory motor function following hypoxic ischemic injury in neonatal rats | Q28539828 | ||
| ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons | Q28568735 | ||
| Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 | ||
| VEGF links hippocampal activity with neurogenesis, learning and memory | Q28578381 | ||
| VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants | Q28579192 | ||
| Decreased expression of synapse-related genes and loss of synapses in major depressive disorder | Q28580177 | ||
| Essential role of brain-derived neurotrophic factor in adult hippocampal function | Q28593001 | ||
| The Organization of Networks within the Orbital and Medial Prefrontal Cortex of Rats, Monkeys and Humans | Q29042252 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists | Q29618120 | ||
| Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress | Q29618764 | ||
| 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression | Q29618835 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Neurobiology of depression | Q29619932 | ||
| A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome | Q30431760 | ||
| Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression | Q30439257 | ||
| Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression | Q30448565 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Antidepressants increase neural progenitor cells in the human hippocampus | Q30482397 | ||
| Gender-specific impact of brain-derived neurotrophic factor signaling on stress-induced depression-like behavior | Q30489843 | ||
| NGF is essential for hippocampal plasticity and learning | Q30491147 | ||
| Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. | Q30493524 | ||
| Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression | Q30521434 | ||
| Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression | Q36279126 | ||
| The fibroblast growth factor family: neuromodulation of affective behavior | Q36334413 | ||
| A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays | Q36361793 | ||
| Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. | Q36364292 | ||
| Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. | Q36409600 | ||
| An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression | Q36450098 | ||
| The fibroblast growth factor system and mood disorders. | Q36456340 | ||
| The fibroblast growth factor system is downregulated following social defeat | Q36456617 | ||
| VEGF as a potential target for therapeutic intervention in depression | Q36484900 | ||
| Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect | Q36534349 | ||
| Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy | Q36600369 | ||
| Glial reduction in the subgenual prefrontal cortex in mood disorders | Q36651128 | ||
| Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments | Q36672294 | ||
| Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. | Q36684306 | ||
| Neural substrates of increased memory sensitivity for negative stimuli in major depression | Q36776052 | ||
| Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies | Q36813765 | ||
| Neuronal plasticity and antidepressant actions | Q36828335 | ||
| Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus | Q36837563 | ||
| Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior. | Q36850547 | ||
| Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study | Q36857790 | ||
| Antidepressant-like effects of intracerebroventricular FGF2 in rats | Q36868670 | ||
| Brain-derived Neurotrophic Factor in Megakaryocytes | Q36876290 | ||
| Adult hippocampal neurogenesis in depression | Q36921967 | ||
| Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. | Q36926866 | ||
| Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization | Q36960380 | ||
| A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome | Q37008339 | ||
| Depression and hippocampal neurogenesis: a road to remission? | Q37131367 | ||
| Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice | Q37257617 | ||
| Dynamics of the dopaminergic system as a key component to the understanding of depression | Q37260914 | ||
| Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission | Q37286014 | ||
| Amygdala hyperactivation in untreated depressed individuals | Q37288575 | ||
| Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise | Q37311897 | ||
| Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder | Q37327193 | ||
| The requirement of BDNF for hippocampal synaptic plasticity is experience-dependent | Q37344077 | ||
| Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway | Q38725380 | ||
| Angiogenesis in refractory depression: A possible phenotypic target to avoid the blood brain barrier | Q38744851 | ||
| Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission. | Q38815980 | ||
| BDNF Val66Met polymorphism and bipolar disorder in European populations: A risk association in case-control, family-based and GWAS studies | Q38847078 | ||
| Neuroprotection elicited by nerve growth factor and brain-derived neurotrophic factor released from astrocytes in response to methylmercury | Q38856582 | ||
| Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users | Q38895482 | ||
| Brain-derived neurotrophic factor in mood disorders and antidepressant treatments | Q38899740 | ||
| Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor | Q38942610 | ||
| Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity | Q39139389 | ||
| GDNF facilitates differentiation of the adult dentate gyrus-derived neural precursor cells into astrocytes via STAT3. | Q39163206 | ||
| Sustained running in rats administered corticosterone prevents the development of depressive behaviors and enhances hippocampal neurogenesis and synaptic plasticity without increasing neurotrophic factor levels. | Q39264866 | ||
| Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood | Q39281544 | ||
| The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies | Q39384358 | ||
| Circulating Glial-derived neurotrophic factor is reduced in late-life depression | Q39465095 | ||
| Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling. | Q39494795 | ||
| Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. | Q39603610 | ||
| Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression | Q39613558 | ||
| The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry | Q39649409 | ||
| The role of growth factors in neuronal development and plasticity. | Q39748406 | ||
| VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia | Q39774417 | ||
| Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study | Q39945027 | ||
| p11 mediates the BDNF-protective effects in dendritic outgrowth and spine formation in B27-deprived primary hippocampal cells | Q39982687 | ||
| Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients | Q40014805 | ||
| Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action | Q40139139 | ||
| Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. | Q40232259 | ||
| Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats | Q40250561 | ||
| Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus | Q40328948 | ||
| Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity | Q40332580 | ||
| p75 and Trk: a two-receptor system | Q40419805 | ||
| The contribution of the amygdala to normal and abnormal emotional states | Q40490212 | ||
| Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats | Q40568805 | ||
| Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. | Q40615506 | ||
| Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. | Q40627680 | ||
| Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression | Q40634513 | ||
| Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells | Q40775520 | ||
| Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage | Q40841418 | ||
| The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression | Q41194085 | ||
| Nerve growth factor (NGF) has novel antidepressant-like properties in rats | Q41199023 | ||
| Nerve growth factor treatment after brain injury prevents neuronal death | Q41478262 | ||
| Mice lacking brain-derived neurotrophic factor develop with sensory deficits | Q41481309 | ||
| Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. | Q41712803 | ||
| The volumes of subcortical regions in depressed and healthy individuals are strikingly similar: a reinterpretation of the results by Schmaal et al. | Q41791098 | ||
| The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex | Q41883330 | ||
| Delayed administration of a small molecule tropomyosin-related kinase B ligand promotes recovery after hypoxic-ischemic stroke | Q42124917 | ||
| Blockade of BDNF signaling turns chemically-induced long-term potentiation into long-term depression. | Q42438468 | ||
| Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons | Q42455392 | ||
| Imipramine enhances cell proliferation and decreases neurodegeneration in the hippocampus after transient global cerebral ischemia in rats. | Q42464981 | ||
| Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons | Q42466343 | ||
| Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. | Q30579956 | ||
| In vivo imaging of adult human hippocampal neurogenesis: progress, pitfalls and promise | Q30594072 | ||
| VEGF and depression: a comprehensive assessment of clinical data | Q30627961 | ||
| A review of fMRI studies during visual emotive processing in major depressive disorder | Q30779268 | ||
| BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. | Q30947753 | ||
| Functional alterations of fronto-limbic circuit and default mode network systems in first-episode, drug-naïve patients with major depressive disorder: A meta-analysis of resting-state fMRI data | Q31131442 | ||
| Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression | Q31833575 | ||
| Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. | Q31840769 | ||
| ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. | Q33200609 | ||
| A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. | Q33397741 | ||
| Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies | Q33411640 | ||
| Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals | Q33500614 | ||
| Insulin-like growth factor-I and central nervous system development | Q33607341 | ||
| Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear | Q33664683 | ||
| Prefrontal cortical networks related to visceral function and mood | Q33692819 | ||
| The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats | Q33712487 | ||
| A meta-analytic study of changes in brain activation in depression | Q33865590 | ||
| Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons | Q33925737 | ||
| Brain anatomy of major depression II. Focus on amygdala. | Q33927879 | ||
| VEGF, a mediator of the effect of experience on hippocampal neurogenesis | Q33993499 | ||
| The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus | Q34024581 | ||
| Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus | Q34072691 | ||
| Cellular changes in the postmortem hippocampus in major depression | Q34090433 | ||
| Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study | Q34101325 | ||
| Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents | Q34111160 | ||
| Reduced volume of orbitofrontal cortex in major depression | Q34124198 | ||
| Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism--a positive feedback circuit in developing neurons | Q34143009 | ||
| Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy | Q34147129 | ||
| Harnessing neuroplasticity for clinical applications | Q34177415 | ||
| Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice | Q34179450 | ||
| How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans | Q34199009 | ||
| Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. | Q34199475 | ||
| The societal costs of chronic major depression | Q34224166 | ||
| fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder | Q37350279 | ||
| Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. | Q37380865 | ||
| Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. | Q37387734 | ||
| The brain reward circuitry in mood disorders | Q37401710 | ||
| The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. | Q37416408 | ||
| Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia | Q37441879 | ||
| Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation | Q37475226 | ||
| Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion. | Q37497297 | ||
| Dysregulation of the fibroblast growth factor system in major depression | Q37585523 | ||
| Deep-brain magnetic stimulation promotes adult hippocampal neurogenesis and alleviates stress-related behaviors in mouse models for neuropsychiatric disorders | Q37591435 | ||
| Functional Circuitry Effect of Ventral Tegmental Area Deep Brain Stimulation: Imaging and Neurochemical Evidence of Mesocortical and Mesolimbic Pathway Modulation | Q37677950 | ||
| Emotion and episodic memory in neuropsychiatric disorders. | Q37708748 | ||
| Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. | Q37781350 | ||
| The effects of repetitive transcranial magnetic stimulation in the treatment of depression | Q37820978 | ||
| Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action | Q37896304 | ||
| The size and burden of mental disorders and other disorders of the brain in Europe 2010. | Q37928182 | ||
| Gene-environment interaction in major depression and antidepressant treatment response | Q37971344 | ||
| Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. | Q37978203 | ||
| TrkB inhibition as a therapeutic target for CNS-related disorders. | Q38019292 | ||
| Synaptic dysfunction in depression: potential therapeutic targets | Q38050123 | ||
| VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration | Q38087877 | ||
| Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. | Q38122158 | ||
| Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). | Q38130092 | ||
| Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. | Q38140658 | ||
| Disorders of memory and plasticity in psychiatric disease | Q38181469 | ||
| BDNF and synaptic plasticity, cognitive function, and dysfunction | Q38199414 | ||
| Interactions between cholinergic and fibroblast growth factor receptors in brain trophism and plasticity | Q38245068 | ||
| Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis | Q38251192 | ||
| BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis | Q38305240 | ||
| VEGF is required for dendritogenesis of newly born olfactory bulb interneurons | Q38347595 | ||
| Adult Neurogenesis in Humans | Q38541786 | ||
| Insulin-like Growth Factors in a clinical setting: Review of IGF-I. | Q38586216 | ||
| Neurobiological effects of exercise on major depressive disorder: A systematic review. | Q38666659 | ||
| Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data | Q34246528 | ||
| Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. | Q34290011 | ||
| Fibroblast growth factors in the developing central nervous system | Q34291413 | ||
| Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression | Q34300190 | ||
| Course of illness, hippocampal function, and hippocampal volume in major depression | Q34331120 | ||
| Dynamics of hippocampal neurogenesis in adult humans | Q34349399 | ||
| 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease | Q34370099 | ||
| 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice | Q34373618 | ||
| Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation | Q34460057 | ||
| Hippocampal volume in relation to clinical and cognitive outcome after electroconvulsive therapy in depression | Q34482343 | ||
| Meta-analysis of Functional Neuroimaging of Major Depressive Disorder in Youth | Q34492077 | ||
| Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. | Q34492381 | ||
| Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist. | Q34496197 | ||
| MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity | Q34511957 | ||
| Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder | Q48464800 | ||
| Reduced serum nerve growth factor in patients with late-life depression | Q48487954 | ||
| Effect of exercise, exercise withdrawal, and continued regular exercise on excitability and long-term potentiation in the dentate gyrus of hippocampus. | Q48490642 | ||
| Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors | Q48541992 | ||
| Epidermal growth factor does not cross the blood-brain barrier | Q48568706 | ||
| Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 | ||
| Decreased serum brain-derived neurotrophic factor levels in major depressed patients | Q48642995 | ||
| Amelioration of delayed neuronal death in the hippocampus by nerve growth factor | Q48661555 | ||
| Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. | Q48668820 | ||
| Neural stem cell proliferation is decreased in schizophrenia, but not in depression. | Q48686220 | ||
| A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis | Q48686925 | ||
| Behavioural stress facilitates the induction of long-term depression in the hippocampus | Q48704490 | ||
| Electroconvulsive seizures stimulate the vegf pathway via mTORC1. | Q48786438 | ||
| Evidence for impaired neocortical synaptic plasticity in bipolar II disorder | Q48809778 | ||
| Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). | Q48824073 | ||
| Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor | Q48876703 | ||
| Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid | Q48879855 | ||
| Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family | Q48888641 | ||
| Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies | Q48974853 | ||
| Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. | Q49067543 | ||
| Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity | Q49079899 | ||
| Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. | Q49084529 | ||
| Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction | Q49116067 | ||
| BDNF effects on dendritic spine morphology and hippocampal function | Q49948865 | ||
| Association of BDNF Val66Met Polymorphism and Brain BDNF levels with Major Depression and Suicide | Q50061520 | ||
| Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults | Q50420534 | ||
| Modulation of synaptic plasticity by short-term aerobic exercise in adult mice | Q50436269 | ||
| Implications of p75NTR for dentate gyrus morphology and hippocampus-related behavior revisited. | Q50682508 | ||
| Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. | Q50907929 | ||
| Amygdala reactivity to emotional faces predicts improvement in major depression. | Q50960727 | ||
| Reduction in hippocampal neurogenesis after social defeat is long-lasting and responsive to late antidepressant treatment. | Q51871270 | ||
| Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. | Q51985283 | ||
| Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
| Hippocampal volume reduction in major depression. | Q52172075 | ||
| Human Hippocampal Neurogenesis Persists throughout Aging. | Q52602379 | ||
| The global burden of disease, 1990–2020 | Q53681952 | ||
| Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia | Q57253718 | ||
| Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity | Q59389004 | ||
| Interactions of IGF-1 with the blood-brain barrier in vivo and in situ | Q73062004 | ||
| Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development | Q73168304 | ||
| Mortality of patients with mood disorders: follow-up over 34-38 years | Q74294155 | ||
| Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
| Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system | Q78003462 | ||
| Enlarged amygdala volume and reduced hippocampal volume in young women with major depression | Q81035260 | ||
| Induction of LTP in the human auditory cortex by sensory stimulation | Q81244319 | ||
| Effects of long-term potentiation in the human visual cortex: a functional magnetic resonance imaging study | Q81551276 | ||
| Fibroblast growth factor-2 deficiency causes defects in adult hippocampal neurogenesis, which are not rescued by exogenous fibroblast growth factor-2 | Q84618128 | ||
| Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons | Q42484843 | ||
| Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews | Q42517465 | ||
| Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. | Q42526405 | ||
| Long-term plasticity of visually evoked potentials in humans is altered in major depression | Q42609601 | ||
| Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. | Q42613013 | ||
| Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice | Q43272468 | ||
| Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis | Q43807507 | ||
| Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. | Q43824666 | ||
| Serotonin is required for exercise-induced adult hippocampal neurogenesis. | Q43836700 | ||
| Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. | Q44085219 | ||
| Outgrowth of sympathetic adrenergic neurons in mice treated with a nerve-growth factor (NGF) | Q44163967 | ||
| Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. | Q44270223 | ||
| Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression | Q44294624 | ||
| Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice | Q44526579 | ||
| Nerve growth factor promotes survival of new neurons in the adult hippocampus | Q44543686 | ||
| Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects | Q44545444 | ||
| Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain | Q44598165 | ||
| A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression | Q44669228 | ||
| Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures | Q44752367 | ||
| Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. | Q44835112 | ||
| Chronic stress alters dendritic morphology in rat medial prefrontal cortex. | Q44987968 | ||
| Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder | Q45079329 | ||
| The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels | Q45080795 | ||
| Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. | Q45293425 | ||
| The effect of acute swim stress and training in the water maze on hippocampal synaptic activity as well as plasticity in the dentate gyrus of freely moving rats: revisiting swim-induced LTP reinforcement. | Q45909001 | ||
| Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. | Q46030165 | ||
| Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. | Q46036521 | ||
| Neural correlates during working memory processing in major depressive disorder | Q46259384 | ||
| The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. | Q46266275 | ||
| Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects | Q46390264 | ||
| Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. | Q46425117 | ||
| Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims | Q46494951 | ||
| A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation. | Q46568659 | ||
| Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. | Q46767739 | ||
| VTA dopamine neuron bursting is altered in an animal model of depression and corrected by desipramine | Q46806816 | ||
| Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress | Q46807733 | ||
| Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning | Q46815353 | ||
| Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration | Q46842547 | ||
| Hippocampal activation during associative encoding of word pairs and its relation to symptomatic improvement in depression: a functional and volumetric MRI study | Q46877873 | ||
| Enhanced production and dendritic growth of new dentate granule cells in the middle-aged hippocampus following intracerebroventricular FGF-2 infusions. | Q46990503 | ||
| Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. | Q47191236 | ||
| Haploinsufficiency in trkB and/or trkC neurotrophin receptors causes structural alterations in the aged hippocampus and amygdala | Q47380697 | ||
| Electrical stimulation of the vmPFC serves as a remote control to affect VTA activity and improve depressive-like behavior | Q47428045 | ||
| Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice. | Q47610479 | ||
| Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses. | Q47640671 | ||
| Repeated fluvoxamine treatment recovers juvenile stress-induced morphological changes and depressive-like behavior in rats | Q47653259 | ||
| Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. | Q47663583 | ||
| Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor. | Q47824544 | ||
| Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer. | Q47845805 | ||
| Disrupted resting-state functional connectivity of the hippocampus in medication-naïve patients with major depressive disorder | Q47967769 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peptide | Q172847 |
| antidepressant | Q76560 | ||
| pharmacology | Q128406 | ||
| neuroplasticity | Q849491 | ||
| pathophysiology | Q1135939 | ||
| mental depression | Q4340209 | ||
| nerve tissue protein | Q6996861 | ||
| nerve growth factors | Q98072643 | ||
| P304 | page(s) | 2195-2220 | |
| P577 | publication date | 2018-06-30 | |
| 2018-08-01 | |||
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression | |
| P478 | volume | 235 |
| Q64101308 | 5-HTT independent effects of fluoxetine on neuroplasticity |
| Q64234863 | Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats |
| Q95320733 | Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study |
| Q91845013 | Chimera dynamics in an array of coupled FitzHugh-Nagumo system with shift of close neighbors |
| Q97517904 | Exercise-Based Interventions for Internet Addiction: Neurobiological and Neuropsychological Evidence |
| Q97519980 | Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis |
| Q92589056 | P2X7 Receptor Signaling in Stress and Depression |
| Q90400043 | Rb1, the Primary Active Ingredient in Panax ginseng C.A. Meyer, Exerts Antidepressant-Like Effects via the BDNF-Trkb-CREB Pathway |
| Q90675090 | Sustained Ultrastructural Changes in Rat Hippocampal Formation after Repeated Electroconvulsive Seizures |
| Q98735784 | The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms |
Search more.